Follow the 株式会社マツキヨココカラ&カンパニー stock price and the full management transaction log of the company, a publicly traded company based in Japan. Shares are quoted on JP JP, under the oversight of EDINET (Japan FSA). Operating in the Health Care sector, 株式会社マツキヨココカラ&カンパニー has logged 5 insider filings. Market capitalisation: €1,005.5bn. The latest transaction was reported on 5 June 2026 (Holding update). Among the most active insiders: BlackRock Japan Co., Ltd.. The full history is free.
Analysts rate 株式会社マツキヨココカラ&カンパニー Buy (bullish), based on 10 analysts. Average price target: JP¥2,976.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
5 of 5 declarations
Matsukiyo Cocokara & Company is a Japanese company specializing in the health and pharmaceutical sector. It primarily operates in the XTKS market.